The influence of nasal continuous positive airway pressure therapy on tumor necrosis factor-α and interleukin-6 in patients with chronic heart failure and severe obstructive sleep apnea syndrome
10.3760/cma.j.issn.1673-4904.2014.10.011
- VernacularTitle:经鼻持续气道正压通气对慢性心力衰竭合并重度阻塞型睡眠呼吸暂停综合征患者血清肿瘤坏死因子-α和白细胞介素-6的影响
- Author:
Changhe LIU
;
Qingzong XU
;
Na HUA
- Publication Type:Journal Article
- Keywords:
Continuous positive airway pressure;
Heart failure;
Sleep apnea,obstructive;
Tumor necrosis factor-alpha;
Interleukin-6
- From:
Chinese Journal of Postgraduates of Medicine
2014;37(10):33-35
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the influence of nasal continuous positive airway pressure (nCPAP) therapy on tumor necrosis factor-ot (TNF-α) and interleukin-6 (IL-6) in patients with chronic heart failure (CHF) and severe obstructive sleep apnea syndrome (OSAS).Methods Seventy-two cases with CHF and severe OSAS were divided into treatment group (36 cases) and control group (36 cases) by random digits table.Treatment group was treated by nCPAP and routine drug while control group only by routine drug treatment for 12 weeks.The changes of TNF-α and IL-6 before and after therapy were observed.Results The serum TNF-αt and IL-6 before treatment between two groups was no significant difference (P＞ 0.05).The serum TNF-αt and IL-6 after 12 weeks treatment in both two groups was significantly lower than that before treatment [treatment group:(29.94 ± 8.27) ng/L vs.(13.17 ± 3.61) ng/L,(92.08 ± 11.88) ng/L vs.(46.17 ± 20.01) ng/L;control group:(28.01 ± 7.21) ng/L vs.(22.13 ± 5.43) ng/L,(96.01 ± 12.19) ng/L vs.(68.66 ± 11.10) ng/L] (P ＜ 0.05),the treatment group decreased more significantly (P ＜ 0.05).Conclusion nCPAP therapy could effectively decrease the levels of TNF-α and IL-6 and reduce inflammation response in patients with CHF and severe OSAS.
